A new indication for the antibody-drug conjugate expands the future clinical potential of the treatment in patients with the rare breast cancer.
Building on a previous report that revealed corrupt business practices among the big 3 PBMs, a second interim report finds that PBMs heightened prices for…
Successfully integrating biosimilars into practices requires careful planning and execution, as they impact virtually all aspects of a practice.
AbstractBackground. Genitourinary syndrome of menopause (GSM) is a prevalent condition with a constellation of symptoms including burning, dryness, dyspare
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
Medical students are faced with a dilemma: for them to learn, enough people have to get sick, with varied and sometimes terrible illnesses. In order…
Objective Large-scale mortality trials require reliable secondary assessments of impairment. We compared the Ages and Stages Questionnaire (ASQ-3), a screening tool self-administered by parents, in…
This cohort study compares differences in patient case mix and clinical outcomes between academic and community hospitals among patients admitted to general medicine in Ontario,…
The FDA cites cancer risk and the Delany Clause in its decision to revoke food and drug uses of the dye.
Brentuximab vedotin is approved for treatment of adult and pediatric with classical Hodgkin lymphoma in combination with chemotherapy.
